Bloomberg Anywhere Remote Login Bloomberg Terminal Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $12.94 USD
Change Today +0.22 / 1.73%
Volume 3.4K
LMAT On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GM
As of 9:50 AM 09/4/15 All times are local (Market data is delayed by at least 15 minutes).

lemaitre vascular inc (LMAT) Snapshot

Open
$12.63
Previous Close
$12.72
Day High
$12.96
Day Low
$12.63
52 Week High
08/3/15 - $14.82
52 Week Low
10/16/14 - $6.48
Market Cap
229.3M
Average Volume 10 Days
124.8K
EPS TTM
$0.34
Shares Outstanding
17.7M
EX-Date
08/18/15
P/E TM
37.9x
Dividend
$0.16
Dividend Yield
1.21%
Current Stock Chart for LEMAITRE VASCULAR INC (LMAT)

Related News

No related news articles were found.

lemaitre vascular inc (LMAT) Related Businessweek News

No Related Businessweek News Found

lemaitre vascular inc (LMAT) Details

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants for the treatment of peripheral vascular disease worldwide. The company provides angioscope, a fiber optic catheter used for viewing the lumen of a blood vessel; carotid shunts to temporarily divert or shut blood to the brain during the removal of plaque from the carotid artery in a carotid endarterectomy surgery; and powered phlebectomy devices that enable less invasive removal of varicose veins. It also offers embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude blood flow; and perfusion catheters that temporarily perfuse blood and other liquids into the vasculature. In addition, the company provides radiopaque tape, a medical-grade tape applied to the skin and provides interventionists to cross-reference between the inside and the outside of a patient’s body, and allows them to locate tributaries or lesions beneath the skin; and remote endarterectomy devices to remove severe atherosclerotic blockages from the arteries of the leg. Further, it offers valvulotomes for use as a bypass vessel to carry blood past diseased arteries to the lower leg or the foot; vascular grafts to bypass or replace diseased arteries; vascular patches used in conjunction with carotid endarterectomy, remote endarterectomy, and other vascular reconstructions; vessel closure systems that allows surgeons to attach vessels to one another by deploying titanium clips in place of suturing; and laparoscopic cholecystectomy devices to inject dye into the cystic duct during laparoscopic cholecystectomy. LeMaitre Vascular, Inc. markets its products through direct and indirect sales force, as well as distributors. The company was formerly known as Vascutech, Inc. and changed its name to LeMaitre Vascular, Inc. in April 2001. LeMaitre Vascular, Inc. was founded in 1983 and is headquartered in Burlington, Massachusetts.

325 Employees
Last Reported Date: 03/18/15
Founded in 1983

lemaitre vascular inc (LMAT) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $320.6K
President and Director
Total Annual Compensation: $353.2K
Chief Financial Officer, Principal Accounting...
Total Annual Compensation: $247.2K
President of International Operations
Total Annual Compensation: $295.1K
Compensation as of Fiscal Year 2014.

lemaitre vascular inc (LMAT) Key Developments

LeMaitre Vascular, Inc. Presents at 8th Annual Barrington Research Fall Conference 2015, Sep-01-2015

LeMaitre Vascular, Inc. Presents at 8th Annual Barrington Research Fall Conference 2015, Sep-01-2015 . Venue: Four Seasons Hotel Chicago, 900 North Michigan Shops, 120 E Delaware Place, Chicago, IL 60611, United States. Speakers: Joseph P. Pellegrino, Chief Financial Officer, Principal Accounting Officer and Secretary.

LeMaitre Vascular, Inc. Approves Quarterly Dividend, Payable on September 3, 2015; Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Third Quarter Ending September 30, 2015 and Full Year Ending December 31, 2015

On July 23, 2015, LeMaitre Vascular, Inc.'s board of directors approved a quarterly dividend of $0.04 per share of common stock. The dividend will be paid September 3, 2015 to shareholders of record on August 20, 2015. The company reported unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $19,897,000 compared to $18,161,000 for the same period a year ago. Income from operations was of $2,794,000 compared to $1,980,000 for the same period a year ago. Income before income taxes was $2,824,000 compared to $2,000,000 for the same period a year ago. Net income was $1,767,000 or $0.10 per basic and diluted share compared to $1,272,000 or $0.08 per basic and diluted share for the same period a year ago. Adjusted net sales were $20,238,000 against $18,115,000 a year ago. EBITDA was $3,660,000 compared to $2,787,000 for the same period a year ago. Cash from operations was $3.9 million while cash outlays included $1.1 million related to the Tru-Incise acquisition, $700,000 of dividends and $470,000 of capital expenditures. For six months, the company reported net sales of $38,844,000 compared to $34,915,000 for the same period a year ago. Income from operations was of $5,103,000 compared to $1,749,000 for the same period a year ago. Income before income taxes was $5,150,000 compared to $1,727,000 for the same period a year ago. Net income was $3,136,000 or $0.17 per diluted share compared to $1,065,000 or $0.07 per diluted share for the same period a year ago. EBITDA was $6,818,000 compared to $3,344,000 for the same period a year ago. The company provided earnings guidance for the third quarter ending September 30, 2015. The company expects third quarter of 2015 sales of $18.8 million, a reported increase of 7% against third quarter of 2014. Excluding currency effects, this represents 15% sales growth. Excluding currency effects and acquisitions, this represents 10% sales growth (organic growth). The company expects gross margin of 69.0%. The company also expects operating income of $2.2 million (12% operating margin), an increase of 19% against third quarter of 2014. Adjusted net sales expected to be in the range of $19,295,000. Adjusted net sales excluding changes in foreign currency expected to be in the range of $20,170,000. The company provided earnings guidance for the full year ending December 31, 2015. The company has increased its full-year 2015 sales guidance to $77.3 million, a reported increase of 9% against 2014. Excluding currency effects, this represents 16% sales growth. Excluding currency effects and acquisitions, this represents 11% sales growth (organic growth). The company expects 2015 gross margin of 68.5%. The company has increased its 2015 operating income guidance to $9.4 million (12% operating margin), an increase of 48% against 2014. Adjusted net sales expected to be in the range of $79,140,000. Adjusted net sales excluding changes in foreign currency expected to be in the range of $82,700,000.

LeMaitre Vascular, Inc. Presents at Three Part Advisors, LLC Midwest IDEAS Investor Conference 2015, Aug-26-2015 01:50 PM

LeMaitre Vascular, Inc. Presents at Three Part Advisors, LLC Midwest IDEAS Investor Conference 2015, Aug-26-2015 01:50 PM. Venue: Hard Rock Hotel, 230 N. Michigan Ave., Chicago, IL 60601, United States. Speakers: David B. Roberts, President and Director.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LMAT:US $12.94 USD +0.22

LMAT Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CryoLife Inc $9.76 USD -0.04
Hansen Medical Inc $0.56 USD +0.0267
Lombard Medical Inc $3.95 USD 0.00
Stereotaxis Inc $1.18 USD -0.19
Vascular Solutions Inc $33.60 USD -0.09
View Industry Companies
 

Industry Analysis

LMAT

Industry Average

Valuation LMAT Industry Range
Price/Earnings 38.9x
Price/Sales 3.1x
Price/Book 3.3x
Price/Cash Flow 38.6x
TEV/Sales 2.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LEMAITRE VASCULAR INC, please visit www.lemaitre.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.